Survival benefit of high dose therapy over sequential chemotherapy in poor risk aggressive non-Hodgkin's lymphoma. Final analysis of the prospective LNH87-2 protocol. A gela study.

被引：0
|
作者：
Haioun, C [1 ]
Lepage, E [1 ]
Gisselbrecht, C [1 ]
Salles, G [1 ]
Coiffier, B [1 ]
Brice, P [1 ]
Bosly, A [1 ]
Morel, P [1 ]
Nouvel, C [1 ]
Tilly, H [1 ]
Lederlin, P [1 ]
Sebban, C [1 ]
Briere, J [1 ]
Gaulard, P [1 ]
Reyes, F [1 ]
机构：
[1] Hop Henri Mondor, F-94010 Creteil, France
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2711
引用
收藏
页码：610A / 610A
页数：1
相关论文
共 50 条
  • [31] High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma:: a meta-analysis
    Strehl, J
    Mey, U
    Glasmacher, A
    Djulbegovic, B
    Mayr, C
    Gorschlüter, M
    Ziske, C
    Schmidt-Wolf, IGH
    HAEMATOLOGICA, 2003, 88 (11) : 1304 - 1315
  • [32] Tandem high-dose therapy followed by autologous stem-cell transplantation for tefractory or telapsed high-grade non-Hodgkin's lymphoma with poor prognosis factors: A prospective pilot study.
    Le Gouill, S
    Moreau, P
    Morineau, N
    Vigier, M
    Mahe, B
    Rapp, MJ
    Harousseau, JL
    Milpied, N
    BLOOD, 2001, 98 (11) : 394B - 394B
  • [33] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Wang, Jing
    Zhan, Ping
    Ouyang, Jian
    Chen, Bing
    Zhou, Rongfu
    Yang, Yonggong
    MEDICAL ONCOLOGY, 2011, 28 (03) : 822 - 828
  • [34] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Jing Wang
    Ping Zhan
    Jian Ouyang
    Bing Chen
    Rongfu Zhou
    Yonggong Yang
    Medical Oncology, 2011, 28 : 822 - 828
  • [35] A phase II trial of filgrastim (G-CSF) supported high dose sequential chemotherapy and peripheral blood stem cell (PBSC) transplantation as initial therapy for high risk non-Hodgkin's lymphoma(NHL): A multicenter pilot study.
    Schenkein, DP
    Roitman, D
    Miller, KB
    Morelli, J
    Stadtmauer, E
    Pecora, AL
    Cassileth, P
    Lazarus, HM
    BLOOD, 1996, 88 (10) : 462 - 462
  • [36] Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutive ISC trials
    Bouabdallah, R
    Stoppa, AM
    Coso, D
    Bardou, VJ
    Blaise, D
    Chabannon, C
    Gastaut, JA
    Maraninchi, D
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 513 - 517
  • [37] Rituximab-CHOP-ESHAP vs. CHOP-ESHAP-high-dose therapy vs. conventional CHOP chemotherapy in high-risk aggressive non-Hodgkin's lymphoma
    Intragumtornchai, T
    Bunworasate, U
    Nakorn, TN
    Rojnuckarin, P
    ANNALS OF ONCOLOGY, 2005, 16 : 177 - 177
  • [38] Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma
    Intragumtornchai, Tanin
    Bunworasate, Udomsak
    Nakorn, Thanyaphong Na
    Rojnuckarin, Ponlapat
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1306 - 1314
  • [39] Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study
    Choi, SJ
    Ryoo, BY
    Lee, SS
    Park, YH
    Kim, BS
    Kang, YK
    HAEMATOLOGICA, 2002, 87 (05) : 555 - 557
  • [40] Long-term results of a phase-I/II study of sequential high-dose chemotherapy with autologous stem cell transplantation in the initial treatment of aggressive non-Hodgkin's lymphoma
    Welt, Anja
    Schiitt, Philipp
    Derks, Cordula
    Ebeling, Peter
    Muller, Siemke
    Metz, Klaus
    Anhuf, Juergen
    Moritz, Thomas
    Seeber, Siegfried
    Nowrousian, Mohammad Resa
    TUMORI JOURNAL, 2007, 93 (05): : 409 - 416
12345